Dashboard
Manage Tickers

PROK PROKIDNEY CORP.

Nasdaq prokidney.com


$ 2.79 $ -0.09 (-3.13 %)    

Wednesday, 12-Nov-2025 09:56:15 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 619.80 $ -4.98 (-0.8 %)
DIA $ 484.07 $ 3.51 (0.73 %)
SPY $ 683.38 $ -1.41 (-0.21 %)
TLT $ 90.02 $ 0.07 (0.08 %)
GLD $ 380.74 $ 0.58 (0.15 %)
$ 2.8
$ 2.88
$ 2.76 x 2,000
$ 2.81 x 30
$ 2.79 - $ 2.82
$ 0.46 - $ 7.13
893,781
na
842.34M
$ 1.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-17-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-28-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-23-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

prokidney-q3-eps-012-beats-014-estimate-sales-217000k-beat-44250k-estimate
ProKidney Q3 EPS $(0.12) Beats $(0.14) Est...
11/10/2025 21:36:04

ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by ...

prokidney-to-present-late-breaking-poster-on-phase-2-regen-007-trial-results-at-american-society-of-nephrologys-kidney-week
ProKidney To Present LAte-Breaking Poster ...
10/20/2025 11:43:27

WINSTON-SALEM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company&#...

prokidney-corp-signs-new-191m-agreement-to-sell-greensboro-nc-property-after-prior-deal-termination
ProKidney Corp. Signs New $19.1M Agreement...
10/17/2025 20:41:39

As previously disclosed, on May 8, 2025, ProKidney Corp. (the "Company"), through its wholly owned subsidiary, ProKidne...

spac-king-chamath-palihapitiya-tells-retail-investors-to-stay-away-from-his-new-spac
SPAC King Chamath Palihapitiya Tells Retai...
10/02/2025 15:32:31

Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 17:06:18

chamath-palihapitiya-returns-to-spacs-past-18-deals-investments-average-loss-of-14
Chamath Palihapitiya Returns To SPACs: Pas...
08/19/2025 15:53:58

Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the po...

prokidney-q2-eps-013-beats-015-estimate-sales-221000k
ProKidney Q2 EPS $(0.13) Beats $(0.15) Est...
08/12/2025 20:05:44

ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by ...

watching-prokidney-corp-zacks-upgrades-stock-to-strong-buy
Watching ProKidney Corp; Zacks Upgrades St...
07/17/2025 15:52:52

https://www.zacks.com/stock/news/2589077/prokidney-cp-prok-upgraded-to-strong-buy-what-does-it-mean-for-the-stock

ubs-maintains-buy-on-prokidney-raises-price-target-to-8
UBS Maintains Buy on ProKidney, Raises Pri...
07/15/2025 14:23:30

UBS analyst Eliana Merle maintains ProKidney (NASDAQ:PROK) with a Buy and raises the price target from $4 to $8.

simulations-plus-fb-financial-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Simulations Plus, FB Financial And Other B...
07/15/2025 12:40:03

prokidney-confirms-alignment-with-fda-on-accelerated-approval-pathway-for-rilparencel
ProKidney Confirms Alignment With FDA On A...
07/15/2025 11:31:25

FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD ...

prokidney-corp-files-for-common-stock-offering-of-up-to-200m-says-in-the-offering-co-may-offer-and-sell-shares-of-class-a-common-stock
ProKidney Corp Files For Common Stock Offe...
07/14/2025 21:08:39

-SEC Filing

guggenheim-maintains-buy-on-prokidney-raises-price-target-to-7
Guggenheim Maintains Buy on ProKidney, Rai...
07/14/2025 14:40:37

Guggenheim analyst Vamil Divan maintains ProKidney (NASDAQ:PROK) with a Buy and raises the price target from $6 to $7.

guggenheim-maintains-buy-on-prokidney-raises-price-target-to-7
Guggenheim Maintains Buy on ProKidney, Rai...
07/14/2025 14:40:37

Guggenheim analyst Vamil Divan maintains ProKidney (NASDAQ:PROK) with a Buy and raises the price target from $6 to $7.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 17:05:47

azz-posts-better-than-expected-earnings-joins-mp-materials-wk-kellogg-and-other-big-stocks-moving-higher-on-thursday
AZZ Posts Better-Than-Expected Earnings, J...
07/10/2025 15:13:33

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 12:09:22

why-wk-kellogg-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket
Why WK Kellogg Shares Are Trading Higher B...
07/10/2025 09:47:28

citigroup-maintains-buy-on-prokidney-raises-price-target-to-9
Citigroup Maintains Buy on ProKidney, Rais...
07/09/2025 16:09:56

Citigroup analyst Yigal Nochomovitz maintains ProKidney (NASDAQ:PROK) with a Buy and raises the price target from $6 to $9.

prokidney-prok-shares-skyrocket-on-promising-kidney-disease-drug-trial-results
ProKidney (PROK) Shares Skyrocket On Promi...
07/09/2025 15:41:56

ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday driven ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION